T-ALL

7 registered clinical trials studyying T-ALL — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic L NCT06849401	Shanghai Jiao Tong University School of Medicine	EARLY_Phase 1
Recruiting	Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lympho NCT06648889	Goethe University	Phase 2
Recruiting	CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study NCT06136364	Hebei Senlang Biotechnology Inc., Ltd.	Phase 1
Unknown	SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies NCT05398614	Hebei Senlang Biotechnology Inc., Ltd.	Phase 1
Unknown	CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia NCT04785833	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	N/A
Recruiting	CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) NCT04318678	St. Jude Children's Research Hospital	Phase 1
Terminated	Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies NCT03422679	Cellestia Biotech AG	Phase 1 / Phase 2